Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
27.02
-0.10 (-0.37%)
At close: Mar 9, 2026, 4:00 PM EDT
27.07
+0.05 (0.19%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Castle Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Net Income | -24.16 | 18.25 | -57.47 | -67.14 | -31.29 | Upgrade
|
| Depreciation & Amortization | 20.67 | 16 | 12.33 | 10.54 | 3.41 | Upgrade
|
| Asset Writedown & Restructuring Costs | 20.1 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -5.69 | -7.24 | -5.49 | -1.37 | - | Upgrade
|
| Stock-Based Compensation | 45.89 | 50.32 | 51.22 | 36.32 | 21.74 | Upgrade
|
| Other Operating Activities | -6.08 | 1.67 | 0.41 | -20.01 | -8.74 | Upgrade
|
| Change in Accounts Receivable | 6.88 | -12.64 | -14.93 | -6.22 | -4.63 | Upgrade
|
| Change in Inventory | -2.14 | -0.19 | -3.96 | -1.68 | 0.33 | Upgrade
|
| Change in Accounts Payable | 3.08 | -4.37 | 5.71 | 0.58 | -0.18 | Upgrade
|
| Change in Other Net Operating Assets | 5.79 | 3.08 | 6.56 | 7.31 | 0.38 | Upgrade
|
| Operating Cash Flow | 64.35 | 64.87 | -5.63 | -41.66 | -18.98 | Upgrade
|
| Operating Cash Flow Growth | -0.80% | - | - | - | - | Upgrade
|
| Capital Expenditures | -36.02 | -28.33 | -13.62 | -5.63 | -3.48 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.05 | 0.02 | 0.01 | 0.2 | 0.01 | Upgrade
|
| Cash Acquisitions | -18.73 | - | - | -26.42 | -63.18 | Upgrade
|
| Investment in Securities | -3.55 | -21.83 | -2.58 | -134.69 | - | Upgrade
|
| Investing Cash Flow | -60.37 | -50.14 | -16.18 | -166.55 | -66.66 | Upgrade
|
| Long-Term Debt Issued | - | 10 | - | - | - | Upgrade
|
| Total Debt Issued | - | 10 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -0.12 | -0.1 | -0.14 | -0.12 | -0.01 | Upgrade
|
| Total Debt Repaid | -0.12 | -0.1 | -0.14 | -0.12 | -0.01 | Upgrade
|
| Net Debt Issued (Repaid) | -0.12 | 9.9 | -0.14 | -0.12 | -0.01 | Upgrade
|
| Issuance of Common Stock | 4.62 | 5 | 2.98 | 3.33 | 6.55 | Upgrade
|
| Repurchase of Common Stock | -11.66 | -8.76 | -5.13 | -1.69 | -0.78 | Upgrade
|
| Other Financing Activities | 0.19 | - | - | - | -0.34 | Upgrade
|
| Financing Cash Flow | -6.96 | 6.14 | -2.3 | 1.52 | 5.42 | Upgrade
|
| Net Cash Flow | -2.98 | 20.87 | -24.11 | -206.69 | -80.22 | Upgrade
|
| Free Cash Flow | 28.33 | 36.54 | -19.25 | -47.29 | -22.47 | Upgrade
|
| Free Cash Flow Growth | -22.48% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 8.23% | 11.00% | -8.76% | -34.51% | -23.88% | Upgrade
|
| Free Cash Flow Per Share | 0.98 | 1.25 | -0.72 | -1.81 | -0.89 | Upgrade
|
| Cash Interest Paid | 0.06 | 0.43 | 0.01 | 0.02 | 0 | Upgrade
|
| Cash Income Tax Paid | 1.6 | 2.5 | 0.2 | 0.12 | 0.02 | Upgrade
|
| Levered Free Cash Flow | 41.21 | 29.45 | 0.82 | -14.69 | -5.03 | Upgrade
|
| Unlevered Free Cash Flow | 41.27 | 29.81 | 0.83 | -14.68 | -5.03 | Upgrade
|
| Change in Working Capital | 13.6 | -14.13 | -6.63 | -0.01 | -4.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.